Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

June 2021

Dollars and Sense

ByJoseph Alvarnas, MD
June 23rd 2021

FDA Panel Votes to Keep 4 of 6 “Dangling Approvals,” in a Sign of Things to Come

ByMary Caffrey
June 22nd 2021

Observations Regarding the Average Sales Price Reimbursement Methodology

BySusan Weidner, MBA, MS,Michael Diaz, MD,Cass Schaedig,Lucio Gordan, MD
June 21st 2021

Weidner et al, Appendices

BySusan Weidner, MBA, MS,Michael Diaz, MD,Cass Schaedig,Lucio Gordan, MD
June 21st 2021

Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology

Real-World Evidence Is Key to Accelerating Oncology Approvals

ByJennifer B. Christian, PharmD, MPH, PhD
June 21st 2021

PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?

ByAllison Inserro
June 20th 2021
Macmillan

Biosimilars Drive Savings in Medicare’s Oncology Care Model

ByKeely Macmillan, MSPH
June 19th 2021

A Social Worker Leads ACCC, and Her Timing Is Perfect

ByMary Caffrey
June 19th 2021

After PD-1 Inhibitor Indications Are Withdrawn in SCLC, What Now?

ByMary Caffrey
May 26th 2021

Martin J. Edelman, MD, chair of the Department of Hematology/Oncology and associate director for Translational Research at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the the nuances of rescinded indications in small-cell lung cancer.

Advertisement
Advertisement

Trending on AJMC

1

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

2

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity

3

CMS Proposes Permanent Rules for Medicare Drug Price Negotiation

4

AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike

5

CKD Stage, Proteinuria Tied to Higher HCRU in IgAN

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text